Verwandte Artikel zu Inflammation and Lung Cancer
Inhaltsangabe
In recent years there have been various discoveries connecting inflammation and lung cancer and clearly there is growing interest in this area of cancer research. The link between unresolved inflammation and cancer has been well established with estimates that 15% of cancer deaths are inflammation‐related. Evidence for this link includes the following: a) some inflammatory diseases are associated with increased risk of cancer development; b) inflammatory mediators are present surrounding and within most tumors; c) overexpression of inflammatory cytokines increases cancer development and progression in murine studies; d) inhibition of inflammatory mediators decreases cancer development and progression; and e) the use of non‐steroidal anti‐inflammatory drugs (NSAIDs) has been found to decrease cancer incidence and delay progression. The volume will present aspects of the inflammatory tumor microenvironment (TME), its many roles in tumor progression and metastasis, including creation of a hypoxic environment, increased angiogenesis and invasion, changes in expression of micro‐RNAs (miRNAs) and an increase in a stem cell phenotype. The book will also cover the mechanisms of inflammatory mediators. Chronic overexpression of inflammatory mediators in the TME, as seen in smokers and patients with non‐small cell lung cancer (NSCLC), can also lead to increased tumor initiation, progression, invasion and metastasis. The volume will provide a comprehensive perspective of the latest findings and summaries of progress made regarding inflammation and its connection to lung cancer.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Über die Autorin bzw. den Autor
Steven M. Dubinett is Professor of Medicine and Pathology at the David Geffen School of Medicine at UCLA, Senior Associate Dean for Translational Research at UCLA, as well as the Director of the UCLA Lung Cancer Research Program. Building on original discoveries relevant to inflammation in the pathogenesis of lung cancer, he has developed a translational research program which now utilizes these laboratory-based discoveries in the translational research. Dr. Dubinett has received continuous peer-reviewed federal funding for translational lung cancer research for more than 20 years.
Von der hinteren Coverseite
??????????
This volume presents aspects of the inflammatory tumor microenvironment (TME) and its many roles in tumor progression and metastasis, including creation of a hypoxic environment, increased angiogenesis and invasion, changes in expression of microRNAs (miRNAs), and an increase in a stem cell phenotype. The volume also covers the mechanisms of inflammatory mediators. Chronic overexpression of inflammatory mediators in the TME, as seen in smokers and patients with non-small cell lung cancer (NSCLC), can also lead to increased tumor initiation, progression, invasion, and metastasis. The volume will provide a comprehensive perspective of the latest findings and summaries of progress made regarding inflammation and its connection to lung cancer.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Neu kaufen
Diesen Artikel anzeigen
EUR 111,65
EUR 13,80 für den Versand von Vereinigtes Königreich nach USA
Versandziele, Kosten & DauerWeitere beliebte Ausgaben desselben Titels
Suchergebnisse für Inflammation and Lung Cancer
Beispielbild für diese ISBN
Inflammation and Lung Cancer
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. In. Artikel-Nr. ria9781493945115_new
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Inflammation and Lung Cancer
Anbieter: moluna, Greven, Deutschland
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. Artikel-Nr. 447955830
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Inflammation and Lung Cancer
Verlag:
Springer New York, Springer US Okt 2016, 2016
ISBN 10: 1493945114
ISBN 13: 9781493945115
Neu
Taschenbuch
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. Neuware -In recent years there have been various discoveries connecting inflammation and lung cancer and clearly there is growing interest in this area of cancer research.The link between unresolved inflammation and cancer has been well established with estimates that 15% of cancer deaths are inflammation¿related. Evidence for this link includes thefollowing: a) some inflammatory diseases are associated with increased risk of cancer development; b) inflammatory mediators are present surrounding and within most tumors; c) overexpression of inflammatory cytokines increases cancer development and progression in murine studies; d) inhibition of inflammatory mediators decreases cancer development and progression; and e) the use of non¿steroidal anti¿inflammatory drugs (NSAIDs) has been found to decrease cancer incidence and delay progression.The volume will presentaspects of the inflammatory tumor microenvironment (TME), itsmany roles in tumor progression and metastasis, including creation of a hypoxic environment, increased angiogenesis and invasion, changes in expression of micröRNAs (miRNAs) and an increase in a stem cell phenotype. The book will also cover the mechanisms of inflammatory mediators.Chronic overexpression of inflammatory mediators in the TME, as seen in smokers and patients with non¿small cell lung cancer (NSCLC), can also lead to increased tumor initiation, progression, invasion and metastasis.The volume will provide a comprehensive perspective ofthe latest findings and summaries of progress made regardinginflammation and its connection tolung cancer.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 224 pp. Englisch. Artikel-Nr. 9781493945115
Anzahl: 2 verfügbar
Beispielbild für diese ISBN
Inflammation and Lung Cancer
Anbieter: Kennys Bookstore, Olney, MD, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Editor(s): Dubinett, Steven M. Num Pages: 222 pages, 2 black & white illustrations, 3 colour illustrations, 6 black & white tables, biography. BIC Classification: MJCL; MJCM; MMF; MMFM. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 12. Weight in Grams: 349. . 2016. Softcover reprint of the original 1st ed. 2015. paperback. . . . . Books ship from the US and Ireland. Artikel-Nr. V9781493945115
Anzahl: 15 verfügbar
Foto des Verkäufers
Inflammation and Lung Cancer
Verlag:
Springer New York, Springer US, 2016
ISBN 10: 1493945114
ISBN 13: 9781493945115
Neu
Taschenbuch
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - In recent years there have been various discoveries connecting inflammation and lung cancer and clearly there is growing interest in this area of cancer research. The link between unresolved inflammation and cancer has been well established with estimates that 15% of cancer deaths are inflammation-related. Evidence for this link includes the following: a) some inflammatory diseases are associated with increased risk of cancer development; b) inflammatory mediators are present surrounding and within most tumors; c) overexpression of inflammatory cytokines increases cancer development and progression in murine studies; d) inhibition of inflammatory mediators decreases cancer development and progression; and e) the use of non-steroidal anti-inflammatory drugs (NSAIDs) has been found to decrease cancer incidence and delay progression. The volume will present aspects of the inflammatory tumor microenvironment (TME), its many roles in tumor progression and metastasis, including creation of a hypoxic environment, increased angiogenesis and invasion, changes in expression of micro-RNAs (miRNAs) and an increase in a stem cell phenotype. The book will also cover the mechanisms of inflammatory mediators. Chronic overexpression of inflammatory mediators in the TME, as seen in smokers and patients with non-small cell lung cancer (NSCLC), can also lead to increased tumor initiation, progression, invasion and metastasis. The volume will provide a comprehensive perspective of the latest findings and summaries of progress made regarding inflammation and its connection to lung cancer. Artikel-Nr. 9781493945115
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Inflammation and Lung Cancer
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Paperback. Zustand: Brand New. reprint edition. 222 pages. 9.25x6.10x0.53 inches. In Stock. Artikel-Nr. x-1493945114
Anzahl: 2 verfügbar